Position in ADMA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,485,164
-$1,172,620 QoQ
Shares Held
535,862
-14.7% QoQ
Ownership
0.239%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 323 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. ADMA ranks #54 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ADMA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,485,164 | 535,862 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,657,784 | 627,945 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,186,592 | 613,300 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,538,089 | 650,620 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $11,883,081 | 652,558 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $12,343,793 | 622,167 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $10,651,504 | 621,079 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $12,297,808 | 615,198 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,471,826 | 310,539 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,944,987 | 294,695 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,303,328 | 288,347 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,030,073 | 287,730 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,031,812 | 279,624 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $937,958 | 283,371 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $968,428 | 249,595 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $599,220 | 246,593 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $457,605 | 231,114 | Shares | Sole | 2022-08-11 | |
| 2021-03-31 | $113,868 | 64,698 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $125,966 | 64,598 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $139,982 | 58,570 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $203,265 | 69,374 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $140,466 | 48,773 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||